ROCKET LAB CORP (1RKLB.MI) Stock Fundamental Analysis

Europe • Euronext Milan • BIT:1RKLB • US7731211089

62.91 EUR
-0.85 (-1.33%)
Last: Feb 10, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

Taking everything into account, 1RKLB scores 3 out of 10 in our fundamental rating. 1RKLB was compared to 54 industry peers in the Aerospace & Defense industry. 1RKLB scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. 1RKLB shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year 1RKLB has reported negative net income.
  • In the past year 1RKLB has reported a negative cash flow from operations.
  • 1RKLB had negative earnings in each of the past 5 years.
  • In the past 5 years 1RKLB always reported negative operating cash flow.
1RKLB.MI Yearly Net Income VS EBIT VS OCF VS FCF1RKLB.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -8.90%, 1RKLB is doing worse than 85.19% of the companies in the same industry.
  • 1RKLB has a Return On Equity of -15.43%. This is amonst the worse of the industry: 1RKLB underperforms 83.33% of its industry peers.
Industry RankSector Rank
ROA -8.9%
ROE -15.43%
ROIC N/A
ROA(3y)-16.4%
ROA(5y)-18.08%
ROE(3y)-34.28%
ROE(5y)-34.08%
ROIC(3y)N/A
ROIC(5y)N/A
1RKLB.MI Yearly ROA, ROE, ROIC1RKLB.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40 -50

1.3 Margins

  • 1RKLB's Gross Margin of 31.70% is in line compared to the rest of the industry. 1RKLB outperforms 59.26% of its industry peers.
  • 1RKLB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
1RKLB.MI Yearly Profit, Operating, Gross Margins1RKLB.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • 1RKLB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, 1RKLB has more shares outstanding
  • Compared to 5 years ago, 1RKLB has more shares outstanding
  • The debt/assets ratio for 1RKLB is higher compared to a year ago.
1RKLB.MI Yearly Shares Outstanding1RKLB.MI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
1RKLB.MI Yearly Total Debt VS Total Assets1RKLB.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • 1RKLB has an Altman-Z score of 25.62. This indicates that 1RKLB is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of 1RKLB (25.62) is better than 98.15% of its industry peers.
  • 1RKLB has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.32, 1RKLB is in the better half of the industry, outperforming 62.96% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Altman-Z 25.62
ROIC/WACCN/A
WACC9.91%
1RKLB.MI Yearly LT Debt VS Equity VS FCF1RKLB.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 3.18 indicates that 1RKLB has no problem at all paying its short term obligations.
  • 1RKLB has a better Current ratio (3.18) than 94.44% of its industry peers.
  • A Quick Ratio of 2.83 indicates that 1RKLB has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 2.83, 1RKLB belongs to the top of the industry, outperforming 92.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.18
Quick Ratio 2.83
1RKLB.MI Yearly Current Assets VS Current Liabilites1RKLB.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • 1RKLB shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.70%.
  • Looking at the last year, 1RKLB shows a very strong growth in Revenue. The Revenue has grown by 52.42%.
  • The Revenue has been growing by 55.23% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-2.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70%
Revenue 1Y (TTM)52.42%
Revenue growth 3Y91.41%
Revenue growth 5Y55.23%
Sales Q2Q%47.97%

3.2 Future

  • 1RKLB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.40% yearly.
  • Based on estimates for the next years, 1RKLB will show a very strong growth in Revenue. The Revenue will grow by 33.45% on average per year.
EPS Next Y-4%
EPS Next 2Y18.87%
EPS Next 3Y31.99%
EPS Next 5Y32.4%
Revenue Next Year38.18%
Revenue Next 2Y43.88%
Revenue Next 3Y43.35%
Revenue Next 5Y33.45%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
1RKLB.MI Yearly Revenue VS Estimates1RKLB.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 1B 2B 3B 4B 5B
1RKLB.MI Yearly EPS VS Estimates1RKLB.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 -0.4

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • 1RKLB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for 1RKLB. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
1RKLB.MI Price Earnings VS Forward Price Earnings1RKLB.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
1RKLB.MI Per share data1RKLB.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as 1RKLB's earnings are expected to grow with 31.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.87%
EPS Next 3Y31.99%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for 1RKLB!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ROCKET LAB CORP

BIT:1RKLB (2/10/2026, 7:00:00 PM)

62.91

-0.85 (-1.33%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)11-10
Earnings (Next)02-26
Inst Owners57.76%
Inst Owner ChangeN/A
Ins Owners0.73%
Ins Owner ChangeN/A
Market Cap33.60B
Revenue(TTM)554.53M
Net Income(TTM)-197.63M
Analysts80
Price Target74.53 (18.47%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)30.22%
Min EPS beat(2)-11.38%
Max EPS beat(2)71.81%
EPS beat(4)3
Avg EPS beat(4)18.1%
Min EPS beat(4)-11.38%
Max EPS beat(4)71.81%
EPS beat(8)7
Avg EPS beat(8)15.56%
EPS beat(12)8
Avg EPS beat(12)9.83%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.41%
Min Revenue beat(2)0.19%
Max Revenue beat(2)4.63%
Revenue beat(4)2
Avg Revenue beat(4)0.8%
Min Revenue beat(4)-0.99%
Max Revenue beat(4)4.63%
Revenue beat(8)3
Avg Revenue beat(8)-1.04%
Revenue beat(12)5
Avg Revenue beat(12)-0.56%
Revenue beat(16)8
Avg Revenue beat(16)0.96%
PT rev (1m)69.61%
PT rev (3m)43.45%
EPS NQ rev (1m)6.1%
EPS NQ rev (3m)-11.92%
EPS NY rev (1m)0%
EPS NY rev (3m)13.3%
Revenue NQ rev (1m)0.42%
Revenue NQ rev (3m)3.89%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)1.66%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 72.03
P/FCF N/A
P/OCF N/A
P/B 31.18
P/tB 48.05
EV/EBITDA N/A
EPS(TTM)-0.32
EYN/A
EPS(NY)-0.18
Fwd EYN/A
FCF(TTM)-0.36
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS0.87
BVpS2.02
TBVpS1.31
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.9%
ROE -15.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.7%
FCFM N/A
ROA(3y)-16.4%
ROA(5y)-18.08%
ROE(3y)-34.28%
ROE(5y)-34.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 334.43%
Cap/Sales 23.12%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.18
Quick Ratio 2.83
Altman-Z 25.62
F-Score5
WACC9.91%
ROIC/WACCN/A
Cap/Depr(3y)174.96%
Cap/Depr(5y)206.2%
Cap/Sales(3y)19.28%
Cap/Sales(5y)34.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70%
EPS Next Y-4%
EPS Next 2Y18.87%
EPS Next 3Y31.99%
EPS Next 5Y32.4%
Revenue 1Y (TTM)52.42%
Revenue growth 3Y91.41%
Revenue growth 5Y55.23%
Sales Q2Q%47.97%
Revenue Next Year38.18%
Revenue Next 2Y43.88%
Revenue Next 3Y43.35%
Revenue Next 5Y33.45%
EBIT growth 1Y-23.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year37.48%
EBIT Next 3Y42.86%
EBIT Next 5Y36.07%
FCF growth 1Y-71.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-36.74%
OCF growth 3YN/A
OCF growth 5YN/A

ROCKET LAB CORP / 1RKLB.MI FAQ

Can you provide the ChartMill fundamental rating for ROCKET LAB CORP?

ChartMill assigns a fundamental rating of 3 / 10 to 1RKLB.MI.


What is the valuation status for 1RKLB stock?

ChartMill assigns a valuation rating of 1 / 10 to ROCKET LAB CORP (1RKLB.MI). This can be considered as Overvalued.


Can you provide the profitability details for ROCKET LAB CORP?

ROCKET LAB CORP (1RKLB.MI) has a profitability rating of 0 / 10.